Co-founder & CEO
30+ years in biopharma & healthcare, focusing on R&D management, B2B partnerships and value creation strategy. Has engaged with over 100 organizations in biopharma, medical technology and healthcare. Published authority on biopharma R&D partnerships and biotech business models
CHIEF TECHNOLOGY OFFICER
Deep technical capabilities, strong academic network and author of multiple scientific papers on system biology modeling of cardiometabolic diseases. Most recent prior role was leading a data science team at a Boston-based biotech that was acquired for >$2 billion
CHIEF SCIENCE OFFICER
Forbes 30 under 30. Founded The Longevity Labs, whose nutraceutical is now marketed in >14 countries including USA, exited after 3 years. Leadership experience with two other startups in cancer genomics and AI-enabled robotics
Celia Antonio Schell
CHIEF OPERATING OFFICER
14 years experience in clinical research at Novartis and ICON. Recently managed a global Phase III clinical trial of >7,000 cardiovascular patients across 43 countries
Lead DATA SCIENTIST
Accomplished systems biology modeler. Most recently at the European Bioinformatics Institute. Prior to this, conducted academic research including journal papers on systems biology modeling of atherosclerosis
LEAD DISEASE BIOLOGIST
Award-winning renal biologist. Has taken a novel therapeutic from unvalidated target to development candidate for Phase I. Previously at a UK biotech managing drug discovery assays and preclinical development studies
CHIEF OF STAFF & FINANCE MANAGER
Broad experience base of international collaborative activities. Product manager in a B2B financial data & solutions provider. Project manager in an energy & fintech business. Founded & exited own business
Experienced at analyzing and interpreting multi-omic patient and in vitro/in vivo data. Previously in the translational medicine data science team at Benevolent AI
BUSINESS DEVT. & ALLIANCE MGMT.
Analyst working across the bioscience and business interface with Master’s degree in Bioscience Entrepreneurship and Bachelor’s degree in biochemistry. Previous experience working in a range of healthcare-centred roles, spanning project support in primary care training to life sciences public relations
PARTNERSHIPS & CORPORATE DEVT.
Analyst working at the cross-section of business and bioscience, with an MSc in Bioscience Entrepreneurship and a BSc in Biomedical Sciences. Prior experience includes working in bioscience SMEs across marketing and business development functions, as well as pharmaceutical R&D
Experienced at analyzing high-dimensional omics datasets and building bioinformatics pipelines. Previously a postdoc at Imperial College London
SCIENCE & BUSINESS ANALYST
Previously interned at Immunocore, AstraZeneca and the Wellcome Sanger Institute
SCIENTIFIC ADVISORY BOARD
Dr. Angeli Möller
ROCHE PHARMACEUTICALS DIVISION, SWITZERLAND
Head of Pharma International Informatics
Alliance for Artificial Intelligence in Healthcare (AAIH) EXECUTIVE OFFICER & CO-FOUNDER
Dr. Richard Nkulikiyinka
Vice-PresidenT, Head of Therapeutic Area Cardiology, Nephrology & Pulmonology
CHIEF SCIENTIFIC OFFICER
director of biology
Want to be a part of our team?
Got a partnership in mind?
Get in touch with us and know more about how we are changing the face of healthcare.
Multiomic Health Limited is a registered UK company